The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

1999/05/01 by G Riegger, G. Riegger · 121 citations
Medicine · #Angina #Cardiac Imaging and Diagnostics #Cardiology #Cardiovascular Effects of Exercise #Coronary artery disease #Discontinuation #Fluvastatin #Incidence (geometry) #Internal medicine #Lipoproteins and Cardiovascular Health #Medicine #Myocardial infarction #Placebo #Simvastatin #Unstable angina

paper · doi:10.1016/s0021-9150(99)00062-3

published in Atherosclerosis 144(1), 263-270 (Elsevier BV)

openalex publication_date 1999/05/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Citations

• Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

Cited by

• Statin Therapy in the Prevention of Recurrent Cardiovascular Events
• Medication-Attributed Adverse Effects in Placebo Groups
• Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia. [europepmc]
• Trends in the Use of Evidence-based Therapies Early in the Course of Acute Myocardial Infarction and its Influence on Short Term Patient Outcomes. [europepmc]
• Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative. [europepmc]
• Fluvastatin for lowering lipids. [europepmc]
• Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants. [europepmc]
• All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials. [europepmc]